21 hasil untuk "Matthieu Groh"

(A Critical Appraisal of) Classification of Hypereosinophilic Disorders

Jean Emmanuel Kahn; Matthieu Groh; Guillaume Lefèvre

Frontiers in Medicine, Vol. 4 · 2017 · Inggris · DOAJ Scopus

Hypereosinophilia (HE) is a heterogeneous condition that can be reported in various (namely inflammatory, allergic, infectious, or neoplastic) diseases with distinct pathophysiological pathways. In 1975, Chusid et al. published the first diagnostic criteria of hypereosinophilic syndromes (HES)…

Interleukin-1/6 Blockade for the Treatment of Severe Steroid-Refractory BNT162b2 Vaccine-Induced Adult-Onset Still’s Disease

Benjamin Hugues; Hakim Ben Amer; Floriane Bril dkk.

European Journal of Case Reports in Internal Medicine (2022) · 2022 · Inggris · DOAJ Scopus

Introduction: Several immune-mediated side effects have been reported with COVID-19 vaccines, including myocarditis. Case description: A 27-year-old woman with a past medical history of mild COVID-19, developed adult-onset Still’s disease (AOSD) with salmon-pink flagellate erythema, polyarthritis…

Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma

Nina Vincent-Galtié; Quentin Marquant; Emilie Catherinot dkk.

Respiratory Research, Vol. 25 No. 1 · 2024 · Inggris · DOAJ Scopus

Abstract Conventional immunosuppressants are ineffective for the management of EGPA-related asthma. Tezepelumab is a human monoclonal antibody that inhibits thymic stromal lymphopoietin (TLSP) that has proven efficacy in several phase 3 studies for the treatment of asthma. We treated with off-label…

Rescue of Eosinophilic Cardiac Tamponade by Anakinra in a Pregnant Woman With Familial Mediterranean Fever

Maxime Quaggetto; Matthieu Groh; Lea Savey dkk.

Case Reports in Immunology, Vol. 2026 · 2026 · Inggris · DOAJ Scopus

Familial Mediterranean fever (FMF) is an interleukin-1 (IL-1)-driven autoinflammatory disease in which pericarditis, occasionally complicated by cardiac tamponade, is a recognized manifestation, whereas hypereosinophilia is not. We report a woman in her thirties with FMF (homozygous MEFV M694V…

Regression of Coronary Aneurysms With Intravenous Immunoglobulins and Steroids for COVID-19 Adult Multisystem Inflammatory Syndrome

Sarah Diakite, MD; Nadine Bousdira, MD; Guillaume Tachon, MD dkk.

JACC: Case Reports, Vol. 3 No. 4 · 2021 · Inggris · DOAJ Scopus

A multisystem inflammatory syndrome mimicking Kawasaki disease has been increasingly reported, mainly in children, in the context of coronavirus disease-2019 (COVID-19). We report on the first case of coronary aneurysm resolution after treatment with steroids and intravenous immunoglobulins in an…

Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis

Enrico Ammirati; Emanuele Bizzi; Giacomo Veronese dkk.

Frontiers in Medicine, Vol. 9 · 2022 · Inggris · DOAJ Scopus

The field of inflammatory disease of the heart or “cardio-immunology” is rapidly evolving due to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial inflammation. In acute myocarditis, recent data on the use of immunomodulating therapies have been reported both in…

Acute Lung, Heart, Liver, and Pancreatic Involvements with Hyponatremia and Retinochoroiditis in a 33-Year-Old French Guianan Patient

Matthieu Groh; Alexandra Faussart; Isabelle Villena dkk.

PLoS Neglected Tropical Diseases, Vol. 6 No. 10 · 2012 · Inggris · PLOS Scopus

Juga tersedia di: DOAJ

Targeting CCR4 with mogamulizumab in refractory CD3-CD4+ lymphocytic-variant hypereosinophilic syndrome

Emmanuel Ledoult; Matthieu Groh; Bertrand Meresse dkk.

Haematologica, Vol. 109 No. 6 · 2024 · Inggris · DOAJ Scopus

Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature review

Elisa Chapuis; Elodie Bousquet; Jean-François Viallard dkk.

Frontiers in Immunology, Vol. 15 · 2024 · Inggris · DOAJ Scopus

IntroductionEosinophils have widespread procoagulant effects. In daily practice, eosinophil-related cardiovascular toxicity consists of endomyocardial damage, eosinophilic vasculitis and arterial or venous thrombosis. Here we aim to report on the clinical features and treatment outcomes of patients…

Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database

Quentin Scanvion; Johana Béné; Sophie Gautier dkk.

OncoImmunology, Vol. 9 No. 1 · 2020 · Inggris · DOAJ Scopus

A better understanding of immune-related adverse events is essential for the early detection and appropriate management of these phenomena. We conducted an observational study of cases recorded at the French reference center for hypereosinophilic syndromes and in the French national…

Causes of acute respiratory failure in patients with small-vessel vasculitis admitted to intensive care units: a multicenter retrospective study

Aude Gibelin; Guillaume Dumas; Sandrine Valade dkk.

Annals of Intensive Care, Vol. 11 No. 1 · 2021 · Inggris · DOAJ Scopus

Abstract Rationale Acute respiratory failure (ARF) in patients admitted to the intensive care unit (ICU) with known or de novo small-vessel vasculitis (Svv) may be secondary to the underlying immune disease or to other causes. Early identification of the cause of ARF is essential to initiate the…

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

Mikael Ebbo; Aurélie Grados; Maxime Samson dkk.

PLOS ONE, Vol. 12 No. 9 · 2017 · Inggris · PLOS Scopus

Objectives: To assess efficacy and safety of rituximab (RTX) as induction therapy, maintenance of remission and treatment of relapses in a cohort of IgG4-related disease (IgG4-RD) patients. Methods: Nationwide retrospective multicenter study of IgG4-RD patients treated with at least one course of…

Juga tersedia di: DOAJ

Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial

Alexandra Audemard-Verger; Amélie Le Gouge; Vincent Pestre dkk.

PLOS ONE, Vol. 17 No. 8 · 2022 · Inggris · PLOS Scopus

Objective: We aimed to investigate whether anakinra, an interleukin-1receptor inhibitor, could improve outcome in moderate COVID-19 patients. Methods: In this controlled, open-label trial, we enrolled adults with COVID-19 requiring oxygen. We randomly assigned patients to receive intravenous…

Juga tersedia di: DOAJ, DOAJ

Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants

Camille Chauvin; Laurine Levillayer; Mathilde Roumier dkk.

iScience, Vol. 26 No. 3 · 2023 · Inggris · DOAJ Scopus

Summary: Although tocilizumab treatment in severe and critical coronavirus disease 2019 (COVID-19) patients has proven its efficacy at the clinical level, there is little evidence supporting the effect of short-term use of interleukin-6 receptor blocking therapy on the B cell sub-populations and…

Venous thrombosis and predictors of relapse in eosinophil-related diseases

Valériane Réau; Alexandre Vallée; Benjamin Terrier dkk.

Scientific Reports, Vol. 11 No. 1 · 2021 · Inggris · DOAJ Scopus

Abstract Eosinophils have widespread procoagulant effects. Eosinophilic cardiovascular toxicity mostly consists of endomyocardial damage or eosinophilic vasculitis, while reported cases of venous thrombosis (VT) are scarce. We aimed to report on the clinical features and treatment outcomes of…

French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes

Matthieu Groh; Julien Rohmer; Nicolas Etienne dkk.

Orphanet Journal of Rare Diseases, Vol. 18 No. 1 · 2023 · Inggris · DOAJ Scopus

Abstract Eosinophilic-related clinical manifestations are protean and the underlying conditions underpinning eosinophilia are highly diverse. The etiological workup of unexplained eosinophilia/hypereosinophilia can be challenging, and can lead sometimes to extensive, inappropriate, costly and/or…